Results 121 to 130 of about 15,794,740 (302)
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Institute on Community Integration Annual Report: 1989-90
, 1990 Note on language: In earlier RISP products, we used the word "retardation" to refer to IDD. Historically, this was common language in the profession and broader society. Because of its broad and common use, outdated language may also appear in other RISP
Institute on Community Integration
core
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Towards optimizing the service pathway “back to work” for people with acquired brain injury
Frontiers in Health ServicesIntroductionRising costs and increasing complexity place growing pressure on healthcare and social security systems worldwide. For people with acquired brain injury (ABI), successful return to work (RTW) depends not only on medical recovery but also on ...
Katarzyna Karcz +8 more
doaj +1 more source
Molecular Oncology, EarlyView.Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Molecular Oncology, EarlyView.The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Participation in social development and integration in Sub-Saharan Africa
, 1986 Discusses participation in social development and integration in Sub-Saharan Africa in terms of economic and social ...
Agere, Sam
core
Social Integration and Mental Health Promotion: A Study of Black Adolescents [PDF]
, 2011 Session 5: Strengths. Presenter: Theda Rose, Ph.D., Catholic University of America (2010) - "Social Integration and Mental Health Promotion: A Study of Black Adolescents".The Ohio State University College of Social ...
Rose, Theda
core +1 more source
Molecular Oncology, EarlyView.Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Molecular Oncology, EarlyView.LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source